Exodus Point Capital Management, LP Immuneering Corp Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Immuneering Corp stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 1,516,833 shares of IMRX stock, worth $9.71 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,516,833Holding current value
$9.71 Million% of portfolio
0.11%Shares
4 transactions
Others Institutions Holding IMRX
# of Institutions
62Shares Held
10.1MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.42MShares$15.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.8MShares$11.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA950KShares$6.08 Million0.72% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il943KShares$6.04 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY550KShares$3.52 Million1.56% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $169M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...